Table 3 Traditional HRV measurements and CI in patients with DRE and healthy control subjects.
Variables | DRE patients (n = 63) | Healthy control subjects (n = 50) | P value |
---|---|---|---|
Traditional HRV analysis | |||
Mean RR (msec) | 713 ± 95 | 762 ± 85 | 0.003 |
SDNN (msec) | 122 ± 36 | 157 ± 36 | <0.001 |
RMSSD (msec) | 34 ± 17 | 46 ± 19 | <0.001 |
pNN50 (%) | 11.58 ± 9.74 | 18.20 ± 10.13 | <0.001 |
VLF (msec.2) | 127 ± 84 | 208 ± 87 | <0.001 |
LF (msec.2) | 584 ± 422 | 1144 ± 750 | <0.001 |
HF (msec.2) | 618 ± 808 | 1073 ± 944 | <0.001 |
TP (msec.2) | 1331 ± 1175 | 2428 ± 1554 | <0.001 |
LF/HF | 1.42 ± 0.94 | 1.58 ± 1.04 | 0.397 |
MSE analysis | |||
Slope 5 | 0.08 ± 0.05 | 0.11 ± 0.06 | 0.001 |
Area 1–5 | 4.79 ± 1.12 | 5.52 ± 0.90 | <0.001 |
Area 6–15 | 12.79 ± 2.23 | 14.40 ± 1.33 | <0.001 |
Area 6–20 | 20.03 ± 3.45 | 22.39 ± 2.02 | <0.001 |